| Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer GV Glinsky, O Berezovska, AB Glinskii The Journal of clinical investigation 115 (6), 1503-1521, 2005 | 1083 | 2005 |
| Gene expression profiling predicts clinical outcome of prostate cancer GV Glinsky, AB Glinskii, AJ Stephenson, RM Hoffman, WL Gerald The Journal of clinical investigation 113 (6), 913-923, 2004 | 594 | 2004 |
| Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity AD Schimmer, K Welsh, C Pinilla, Z Wang, M Krajewska, MJ Bonneau, ... Cancer cell 5 (1), 25-35, 2004 | 548 | 2004 |
| Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium VV Glinsky, GV Glinsky, OV Glinskii, VH Huxley, JR Turk, VV Mossine, ... Cancer research 63 (13), 3805-3811, 2003 | 350 | 2003 |
| The role of Thomsen-Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium VV Glinsky, GV Glinsky, K Rittenhouse-Olson, ME Huflejt, OV Glinskii, ... Cancer research 61 (12), 4851-4857, 2001 | 336 | 2001 |
| Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells O Berezovskaya, AD Schimmer, AB Glinskii, C Pinilla, RM Hoffman, ... Cancer research 65 (6), 2378-2386, 2005 | 299 | 2005 |
| MDA-MB-435 human breast carcinoma cell homo-and heterotypic adhesion under flow conditions is mediated in part by Thomsen-Friedenreich antigen-galectin-3 interactions SK Khaldoyanidi, VV Glinsky, L Sikora, AB Glinskii, VV Mossine, TP Quinn, ... Journal of Biological Chemistry 278 (6), 4127-4134, 2003 | 251 | 2003 |
| Mechanical entrapment is insufficient and intercellular adhesion is essential for metastatic cell arrest in distant organs OV Glinskii, VH Huxley, GV Glinsky, KJ Pienta, A Raz, VV Glinsky Neoplasia 7 (5), 522-527, 2005 | 229 | 2005 |
| Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on β-galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast … VV Glinsky, ME Huflejt, GV Glinsky, SL Deutscher, TP Quinn Cancer research 60 (10), 2584-2588, 2000 | 212 | 2000 |
| Genomic models of metastatic cancer: functional analysis of death-from-cancer signature genes reveals aneuploid, anoikis-resistant, metastasis-enabling phenotype with altered … GV Glinsky Cell cycle 5 (11), 1208-1216, 2006 | 204 | 2006 |
| Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer OP Berezovska, AB Glinskii, Z Yang, X Li, RM Hoffman, GV Glinsky CELL CYCLE-LANDES BIOSCIENCE- 5 (16), 1886, 2006 | 196 | 2006 |
| “Stemness” genomics law governs clinical behavior of human cancer: implications for decision making in disease management GV Glinsky Journal of Clinical Oncology 26 (17), 2846-2853, 2008 | 195 | 2008 |
| Hormonal aspects of breast cancer: growth factors, drugs and stromal interactions R Clarke, RB Dickson, ME Lippman Critical reviews in oncology/hematology 12 (1), 1-23, 1992 | 192 | 1992 |
| Apoptosis and metastasis: increased apoptosis resistance of metastatic cancer cells is associated with the profound deficiency of apoptosis execution mechanisms GV Glinsky, VV Glinsky, AB Ivanova, CJ Hueser Cancer letters 115 (2), 185-193, 1997 | 173 | 1997 |
| Resistance to apoptosis in human cells conferred by telomerase function and telomere stability SE Holt, VV Glinsky, AB Ivanova, GV Glinsky Molecular carcinogenesis 25 (4), 241-248, 1999 | 171 | 1999 |
| Tripartite combination of candidate pandemic mitigation agents: vitamin D, quercetin, and estradiol manifest properties of medicinal agents for targeted mitigation of the COVID … GV Glinsky Biomedicines 8 (5), 129, 2020 | 155 | 2020 |
| Death-from-cancer signatures and stem cell contribution to metastatic cancer GV Glinsky Cell Cycle 4 (9), 1171-1175, 2005 | 148 | 2005 |
| Apoptosis and metastasis: a superior resistance of metastatic cancer cells to programmed cell death GV Glinsky, VV Glinsky Cancer letters 101 (1), 43-51, 1996 | 142 | 1996 |
| Modification of survival pathway gene expression in human breast cancer cells by tetraiodothyroacetic acid (tetrac) AB Glinskii, GV Glinsky, HY Lin, HY Tang, M Sun, FB Davis, MK Luidens, ... Cell Cycle 8 (21), 3562-3570, 2009 | 138 | 2009 |
| Galectin-3 as a potential therapeutic target in tumors arising from malignant endothelia KD Johnson, OV Glinskii, VV Mossine, JR Turk, TP Mawhinney, ... Neoplasia 9 (8), 662-670, 2007 | 136 | 2007 |
Shaker MousaPresident R&D Vascular Vision Pharmaceuticals Co在 vvpharma.com 的电子邮件经过验证
